| Financial Year |
March 31 2023 |
| Monetary Funds |
1,085,655,939.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
101,234,774.55 |
| Advances to Suppliers |
69,929,448.18 |
| Other Receivables |
23,264,822.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,485,193,905.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,284,194.47 |
| Total Current Assets |
2,767,563,085.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,176,287.94 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,907,237,052.10 |
| Under-construction Projects |
1,227,549,301.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
455,099,234.91 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,320,285.57 |
| R&D expenses |
-- |
| Goodwill |
610,191,264.12 |
| Long-Term Deferred and Prepaid Expenses |
7,602,136.64 |
| Deferred Income Tax Assets |
48,098,083.68 |
| Other Non-Current Assets |
145,133,253.80 |
| Sub-Total of Non-Current Assets |
4,866,886,082.39 |
| Total Assets |
7,634,449,167.47 |
| Short-Term Loans |
854,722,273.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
114,000,000.00 |
| Accounts Payable |
470,113,295.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
118,090,134.46 |
| Taxes Payable |
6,561,836.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
303,584,599.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
574,410,019.92 |
| Other Current Liabilities |
190,806.14 |
| Sub-Total of Current Liabilities |
2,478,644,917.27 |
| Long-term Loans |
576,157,200.27 |
| Bonds Payable |
781,411,182.93 |
| Long-Term Accounts Payable |
54,134,544.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,645,688.49 |
| Deferred Income Tax Liabilities |
5,236,764.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,653,651,106.43 |
| Total Liabilities |
4,132,296,023.70 |
| Paid-In Capital(Or Share Stock) |
506,097,908.00 |
| Capital Surplus |
2,210,497,539.86 |
| Surplus Reserve |
35,720,880.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
467,627,805.58 |
| Minority Stockholder's Interest |
37,368,898.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,464,784,245.43 |
| Owner's Equity（Stockholder's Equity） |
3,502,153,143.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,634,449,167.47 |
